Andrew Miller, Ph.D., is the founder of Karuna Therapeutics, a biotechnology company focused on developing novel therapies for neurological disorders.
Andrew Miller, Ph.D., is the founder of Karuna Therapeutics, a biotechnology company focused on developing novel therapies for neurological disorders. He was appointed to the Board of Directors of Alto Neuroscience in 2026. His work centers on advancing treatments for conditions such as schizophrenia and other brain diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library